Berlin - Delayed Quote EUR

Carmat (CXT.BE)

1.0680

-0.0360

(-3.26%)

At close: January 17 at 7:33:04 PM GMT+1

CARMAT Announces Its Participation in Several Scientific and Investor Conferences During the 1st Half of 2025

PARIS, January 13, 2025--CARMAT announces its participation in several scientific and investor conferences during the 1st half of 2025

Business Wire 5 days ago

ALCAR.PA
CARMAT Delivers a Solid FY 2024 with 42 Implants of Its Aeson® Artificial Heart and Anticipates Continued Strong Momentum in 2025

PARIS, January 08, 2025--Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the "Company" or "CARMAT"), announces its 2024 annual sales2 and provides an update on its development outlook.

Business Wire 10 days ago

ALCAR.PA
CARMAT optimizes its financial structure by buying-back, for a symbolic sum of one euro, 2 million shares from Matra-Défense (Airbus group) which will be allocated to the repayment of its financial debt

PARIS, December 23, 2024--CARMAT optimizes its financial structure by buying-back, for a symbolic sum of one euro, 2 million shares from Matra-Défense (Airbus group)

Business Wire 26 days ago

ALCAR.PA
Successful first "Aeson® European User Meeting", marking an important step in the deployment of CARMAT's artificial heart

PARIS, November 26, 2024--Successful first "Aeson® European User Meeting", marking an important step in the deployment of CARMAT's artificial heart

Business Wire last month

ALCAR.PA
CARMAT's Aeson® Artificial Heart Is Gradually Becoming a Reference Solution for Bridge to Transplant in Europe

PARIS, November 13, 2024--CARMAT's Aeson® artificial heart is gradually becoming a reference solution for bridge to transplant in Europe.

Business Wire 2 months ago

ALCAR.PA
Half of Enrolments Targeted in the EFICAS Study Reached by CARMAT

PARIS, September 12, 2024--Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the "Company" or "CARMAT"), today announces that it has reached half of the enrolments targeted in the EFICAS study.

Business Wire 4 months ago

ALCAR.PA
CARMAT Publishes Its 2024 Half-Year Results and Provides an Update on Its Outlook

PARIS, September 06, 2024--Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the "Company" or "CARMAT"), today announces its results for the first half ending June 30, 20242, and provides an update on its progress and prospects.

Business Wire 4 months ago

ALCAR.PA
CARMAT Announces Its Participation in Several Scientific and Investor Conferences during the 2nd Half of 2024

PARIS, September 03, 2024--CARMAT announces its participation in several scientific and investor conferences during the 2nd half of 2024

Business Wire 4 months ago

ALCAR.PA
CARMAT accelerates its sales momentum and reiterates its confidence in its development outlook

PARIS, July 09, 2024--Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the "Company" or "CARMAT"), provides an update on its achievements over the first half of 2024 and reiterates its confidence in its development outlook.

Business Wire 6 months ago

CKMTF
CARMAT to Provide a Half-Year Update on July 9, 2024

PARIS, July 08, 2024--Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the "Company" or "CARMAT"), will publish a half-year update on Tuesday, July 9, 2024 before the market opens.

Business Wire 6 months ago

CKMTF
CARMAT Secures an Equity Financing Line With Vester Finance

PARIS, July 05, 2024--CARMAT secures an equity financing line with Vester Finance

Business Wire 6 months ago

CKMTF
CARMAT Announces Updates in Its Governance

PARIS, June 25, 2024--Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the "Company" or "CARMAT"), announces the appointment of Mr. Pierre Bastid, Director, as Chairman of the Board of CARMAT, replacing Mr. Alexandre Conroy, who has resigned for personal reasons; and the retirement of Mr. André Muller, Director, foll

Business Wire 6 months ago

CKMTF
CARMAT Announces the Start of the Equitization of the First Tranche of Its EIB Loan

PARIS, June 13, 2024--Regulatory News: CARMAT (Paris:ALCAR):

Business Wire 7 months ago

CKMTF
CARMAT Announces the Approval of All Resolutions Supported by the Board of Directors at Its Annual General Meeting

PARIS, May 30, 2024--Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the "Company" or "CARMAT"), informs its shareholders that the Combined General Meeting (AGM) held on May 30, 2024, was able to validly deliberate, the required quorum having been reached.

Business Wire 7 months ago

CKMTF
CARMAT Continues to Build on Its Momentum in the EFICAS Study and Reiterates Confidence in Its 2024 Outlook

PARIS, May 06, 2024--CARMAT continues to build on its momentum in the EFICAS study and reiterates confidence in its 2024 outlook

Business Wire 8 months ago

CKMTF
CARMAT : Availability of the 2023 Universal Registration Document

PARIS, April 30, 2024--Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the "Company" or "CARMAT"), today announced the publication of the Company’s Universal registration document ("URD") for the year ended December 31, 2023.

Business Wire 8 months ago

CKMTF
CARMAT Announces Its 2023 Annual Results and Provides an Update on Its Progress and Prospects for 2024

PARIS, April 24, 2024--CARMAT announces its 2023 annual results and provides an update on its progress and prospects for 2024

Business Wire 8 months ago

CKMTF
CARMAT Announces Its Participation in Several Scientific and Investor Conferences During the Second Quarter of 2024

PARIS, April 04, 2024--Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the "Company" or "CARMAT"), announces today its participation in the following scientific and investor conferences during the second quarter of 2024:

Business Wire 9 months ago

CKMTF
CARMAT Announces a Final Agreement With All Its Financial Creditors on New Repayment Terms for Its Bank Loans

PARIS, March 22, 2024--Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the "Company" or "CARMAT"), today announces a final agreement with all its financial creditors on new loan repayment terms.

Business Wire 9 months ago

CKMTF
CARMAT Provides Update on the Renegotiation of the Repayment Terms of Its Loans With Its Financial Creditors

PARIS, February 22, 2024--CARMAT provides update on the renegotiation of the repayment terms of its loans with its financial creditors

Business Wire 10 months ago

CKMTF

Performance Overview

Return	CXT.BE	CAC 40
YTD	+3.09%	+5.42%
1-Year	-80.55%	+4.21%
3-Year	-91.78%	+7.93%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Carmat (CXT.BE)

CARMAT Announces Its Participation in Several Scientific and Investor Conferences During the 1st Half of 2025

CARMAT Delivers a Solid FY 2024 with 42 Implants of Its Aeson® Artificial Heart and Anticipates Continued Strong Momentum in 2025

CARMAT optimizes its financial structure by buying-back, for a symbolic sum of one euro, 2 million shares from Matra-Défense (Airbus group) which will be allocated to the repayment of its financial debt

Successful first "Aeson® European User Meeting", marking an important step in the deployment of CARMAT's artificial heart

CARMAT's Aeson® Artificial Heart Is Gradually Becoming a Reference Solution for Bridge to Transplant in Europe

Half of Enrolments Targeted in the EFICAS Study Reached by CARMAT

CARMAT Publishes Its 2024 Half-Year Results and Provides an Update on Its Outlook

CARMAT Announces Its Participation in Several Scientific and Investor Conferences during the 2nd Half of 2024

CARMAT accelerates its sales momentum and reiterates its confidence in its development outlook

CARMAT to Provide a Half-Year Update on July 9, 2024

CARMAT Secures an Equity Financing Line With Vester Finance

CARMAT Announces Updates in Its Governance

CARMAT Announces the Start of the Equitization of the First Tranche of Its EIB Loan

CARMAT Announces the Approval of All Resolutions Supported by the Board of Directors at Its Annual General Meeting

CARMAT Continues to Build on Its Momentum in the EFICAS Study and Reiterates Confidence in Its 2024 Outlook

CARMAT : Availability of the 2023 Universal Registration Document

CARMAT Announces Its 2023 Annual Results and Provides an Update on Its Progress and Prospects for 2024

CARMAT Announces Its Participation in Several Scientific and Investor Conferences During the Second Quarter of 2024

CARMAT Announces a Final Agreement With All Its Financial Creditors on New Repayment Terms for Its Bank Loans

CARMAT Provides Update on the Renegotiation of the Repayment Terms of Its Loans With Its Financial Creditors

Performance Overview